It has been shown that a variety of human and animal cancers escape immune surveillance by decreasing their major histocompatibility complex (MHC) Class I gene expression. The under-representation of HLA antigens in human tumors is usually associated with a poor prognosis. Further, it has been shown that the introduction into tumors of vectors able to drive high expression of Class I genes, or the induction of Class I antigens in tumors by agents such as viruses or IFNs, can prove therapeutic. This novel approach might become a great benefit to cancer patients, one which might be achievable through gene therapy. However, for safety reasons as well as to minimize systemic toxicities, it is important to make such approaches as targeted as possible. The objectives of this proposal are: 1) to identify and characterize both the cellular and viral components responsible for the increased transcriptional activity of certain MHC gene(s) following viral infection, 2) to transfer these components as well as MHC genes proper into human tumor cells via targetable gene therapy vectors recently developed, and 3) to determine the potential therapeutic value of this strategy in animal models.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA022247-20
Application #
2616882
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Finerty, John F
Project Start
1977-08-01
Project End
2003-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
20
Fiscal Year
1998
Total Cost
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Tseng, Jen-Chieh; Zanzonico, Pat B; Levin, Brandi et al. (2006) Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med 47:1136-43
Hurtado, Alicia; Tseng, Jen-Chieh; Meruelo, Daniel (2006) Gene therapy that safely targets and kills tumor cells throughout the body. Rejuvenation Res 9:36-44
Hurtado, Alicia; Tseng, Jen-Chieh; Boivin, Christopher et al. (2005) Identification of amino acids of Sindbis virus E2 protein involved in targeting tumor metastases in vivo. Mol Ther 12:813-23
Tseng, Jen-Chieh; Hurtado, Alicia; Yee, Herman et al. (2004) Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res 64:6684-92
Tseng, Jen-Chieh; Levin, Brandi; Hurtado, Alicia et al. (2004) Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 22:70-7
Tseng, Jen-Chieh; Levin, Brandi; Hirano, Tadamichi et al. (2002) In vivo antitumor activity of Sindbis viral vectors. J Natl Cancer Inst 94:1790-802
Choi, Jung W; Pampeno, Christine; Vukmanovic, Stanislav et al. (2002) Characterization of the transcriptional expression of Notch-1 signaling pathway members, Deltex and HES-1, in developing mouse thymocytes. Dev Comp Immunol 26:575-88
Pampeno, C L; Vallerie, A M; Choi, J et al. (2001) Genomic analysis and localization of murine Deltex, a modulator of notch activity, to mouse chromosome 5 and its human homolog to chromosome 12. DNA Cell Biol 20:141-8
Ishizu, A; Sawai, K; Ikeda, H et al. (2000) Transduction of a murine dominant negative activation transcription factor 1 increases cell surface expression of the class I MHC on a human epidermoid tumor cell line. Int Immunol 12:161-8
Yu, A; Choi, J; Ohno, K et al. (2000) Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex. DNA Cell Biol 19:383-8

Showing the most recent 10 out of 43 publications